| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 DDX12P ERCC4 CHD3 CHD4 ERVK-7 RFC2 ZRANB3 CRY1 DDX11 ERVK-8 EME2 CDK7 | 9.51e-10 | 262 | 103 | 13 | GO:0140097 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.32e-08 | 37 | 103 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.93e-08 | 38 | 103 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 DDX12P ERCC4 CHD3 CHD4 ERVK-7 RFC2 ZRANB3 CRY1 DDX11 SLFN13 DROSHA ERVK-8 METTL16 EME2 CDK7 | 1.93e-07 | 645 | 103 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | endonuclease activity | 5.20e-07 | 136 | 103 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 6.42e-07 | 14 | 103 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.32e-06 | 5 | 103 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRHDE ERVK-6 HDAC6 MIOX CYP4F2 CHD3 CHD4 ERVK-7 ERVK-21 ERVK-9 PTCH1 ZRANB3 USP51 SLFN13 ERVK-8 ERVK-19 CYP4F3 CYP4F11 ALOX12 CA3 | 2.42e-06 | 1189 | 103 | 20 | GO:0046914 |
| GeneOntologyMolecularFunction | nuclease activity | 3.10e-06 | 231 | 103 | 9 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.74e-06 | 21 | 103 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.84e-06 | 46 | 103 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.26e-06 | 127 | 103 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.60e-06 | 7 | 103 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.60e-06 | 7 | 103 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.39e-05 | 152 | 103 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.56e-05 | 10 | 103 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.56e-05 | 10 | 103 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.56e-05 | 10 | 103 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.13e-05 | 11 | 103 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.64e-05 | 2 | 103 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.64e-05 | 2 | 103 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 2.64e-05 | 2 | 103 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 3.67e-05 | 13 | 103 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.87e-05 | 37 | 103 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.42e-05 | 182 | 103 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.66e-05 | 14 | 103 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.73e-05 | 184 | 103 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRHDE ERVK-6 HDAC6 CHD3 CHD4 ERVK-7 ERVK-21 ERVK-9 PTCH1 ZRANB3 USP51 SLFN13 ERVK-8 ERVK-19 CA3 | 5.12e-05 | 891 | 103 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.51e-05 | 79 | 103 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 ERCC4 PTPMT1 ACHE ERVK-7 H6PD ZRANB3 ACOT12 SLFN13 DROSHA NME5 ERVK-8 EME2 CA3 | 6.77e-05 | 807 | 103 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 TRABD2B NRDC PIDD1 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-19 PROC | 7.65e-05 | 430 | 103 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX12P DYNC2H1 CHD3 CHD4 RFC2 ZRANB3 DDX11 SLFN13 ATP1A4 DYNC1H1 DNAH11 CDK7 | 7.66e-05 | 614 | 103 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | adiponectin binding | 7.88e-05 | 3 | 103 | 2 | GO:0055100 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 9.22e-05 | 46 | 103 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX12P DYNC2H1 CHD3 CHD4 RFC2 DDX11 SLFN13 ATP1A4 DYNC1H1 DNAH11 | 9.43e-05 | 441 | 103 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.03e-04 | 18 | 103 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | peptidase activity | TRHDE ERVK-6 TRABD2B NRDC PIDD1 ERVK-7 ERVK-21 ERVK-9 USP51 ERVK-8 ERVK-19 PROC | 1.39e-04 | 654 | 103 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 1.57e-04 | 4 | 103 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.57e-04 | 4 | 103 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | helicase activity | 1.70e-04 | 158 | 103 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.49e-04 | 24 | 103 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 2.61e-04 | 5 | 103 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.96e-04 | 62 | 103 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.56e-04 | 27 | 103 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.98e-04 | 28 | 103 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 5.44e-04 | 7 | 103 | 2 | GO:0008467 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.49e-04 | 129 | 103 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.98e-04 | 136 | 103 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.74e-04 | 35 | 103 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.12e-04 | 37 | 103 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.12e-04 | 37 | 103 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 9.26e-04 | 9 | 103 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.86e-04 | 38 | 103 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.12e-03 | 151 | 103 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.15e-03 | 40 | 103 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.41e-03 | 11 | 103 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 1.51e-03 | 44 | 103 | 3 | GO:0004520 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.70e-03 | 166 | 103 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.73e-03 | 334 | 103 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.01e-03 | 343 | 103 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.07e-03 | 49 | 103 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.30e-03 | 14 | 103 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.65e-03 | 15 | 103 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.65e-03 | 15 | 103 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.81e-03 | 465 | 103 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.98e-03 | 115 | 103 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | icosanoid binding | 3.02e-03 | 16 | 103 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 3.02e-03 | 16 | 103 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.34e-03 | 194 | 103 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 3.82e-03 | 18 | 103 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | DNA nuclease activity | 5.03e-03 | 67 | 103 | 3 | GO:0004536 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.14e-03 | 134 | 103 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.68e-03 | 70 | 103 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 5.69e-03 | 22 | 103 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 5.69e-03 | 22 | 103 | 2 | GO:0016780 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 5.70e-03 | 138 | 103 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 5.86e-03 | 417 | 103 | 7 | GO:0140098 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.70e-03 | 229 | 103 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX12P DYNC2H1 CHD3 CHD4 RFC2 DDX11 SLFN13 ATP1A4 DYNC1H1 DNAH11 | 6.70e-03 | 775 | 103 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | histone deacetylase binding | 7.10e-03 | 147 | 103 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 7.90e-03 | 26 | 103 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 9.13e-03 | 28 | 103 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 9.13e-03 | 28 | 103 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 9.13e-03 | 28 | 103 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.69e-03 | 459 | 103 | 7 | GO:0005216 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.97e-07 | 85 | 101 | 7 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.97e-07 | 85 | 101 | 7 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.71e-07 | 89 | 101 | 7 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 DDX12P ERCC4 CHD4 ERVK-7 RFC2 ZRANB3 DDX11 TAF6L USP51 KHDC3L ERVK-8 SMARCD1 EME2 CDK7 | 5.96e-07 | 648 | 101 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 2.26e-06 | 6 | 101 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.68e-06 | 178 | 101 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 DDX12P ERCC4 PIDD1 CHD4 ERVK-7 RFC2 ZRANB3 CRY1 DDX11 TAF6L USP51 KHDC3L ERVK-8 SMARCD1 EME2 CDK7 | 3.87e-06 | 959 | 101 | 17 | GO:0006974 |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 3.93e-06 | 7 | 101 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 6.27e-06 | 8 | 101 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.83e-05 | 11 | 101 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | DNA replication | 2.28e-05 | 312 | 101 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.43e-05 | 12 | 101 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.15e-05 | 13 | 101 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | CACNA1C CACNA1D PTPMT1 PTCH1 CRY1 ADIPOR1 TBC1D1 LRP1 ADIPOR2 | 4.26e-05 | 338 | 101 | 9 | GO:0042593 |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | CACNA1C CACNA1D PTPMT1 PTCH1 CRY1 ADIPOR1 TBC1D1 LRP1 ADIPOR2 | 4.36e-05 | 339 | 101 | 9 | GO:0033500 |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 4.77e-05 | 41 | 101 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 4.77e-05 | 41 | 101 | 4 | GO:0086091 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 6.09e-05 | 16 | 101 | 3 | GO:1904181 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 7.10e-05 | 142 | 101 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 7.10e-05 | 142 | 101 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 7.10e-05 | 3 | 101 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | DNA recombination | 8.19e-05 | 368 | 101 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 8.93e-05 | 48 | 101 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 8.93e-05 | 48 | 101 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | replication fork processing | 1.22e-04 | 52 | 101 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 1.42e-04 | 4 | 101 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 1.42e-04 | 4 | 101 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 1.42e-04 | 4 | 101 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 1.42e-04 | 4 | 101 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.64e-04 | 22 | 101 | 3 | GO:1901569 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | ERCC4 HDAC6 CRY1 DDX11 TAF6L USP51 KHDC3L LRP1 INSIG2 SMARCD1 KDM6A | 1.66e-04 | 598 | 101 | 11 | GO:0080135 |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 1.88e-04 | 23 | 101 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 2.14e-04 | 60 | 101 | 4 | GO:0045005 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2.35e-04 | 5 | 101 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 DDX12P ERCC4 CHD4 ERVK-7 RFC2 ZRANB3 DDX11 TAF6L USP51 KHDC3L ERVK-8 SMARCD1 EME2 CDK7 | 2.42e-04 | 1081 | 101 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 3.47e-04 | 68 | 101 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 3.52e-04 | 6 | 101 | 2 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 3.52e-04 | 6 | 101 | 2 | GO:0062232 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.55e-04 | 73 | 101 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 4.87e-04 | 283 | 101 | 7 | GO:0045926 | |
| GeneOntologyBiologicalProcess | adiponectin-activated signaling pathway | 4.91e-04 | 7 | 101 | 2 | GO:0033211 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 6.19e-04 | 212 | 101 | 6 | GO:0030308 | |
| GeneOntologyBiologicalProcess | acetate ester metabolic process | 6.52e-04 | 8 | 101 | 2 | GO:1900619 | |
| GeneOntologyBiologicalProcess | acetylcholine metabolic process | 6.52e-04 | 8 | 101 | 2 | GO:0008291 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 7.07e-04 | 82 | 101 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.24e-04 | 36 | 101 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | DNA geometric change | 8.45e-04 | 86 | 101 | 4 | GO:0032392 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 8.83e-04 | 87 | 101 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cold-induced thermogenesis | 9.13e-04 | 152 | 101 | 5 | GO:0120161 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 9.45e-04 | 230 | 101 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | cold-induced thermogenesis | 1.03e-03 | 156 | 101 | 5 | GO:0106106 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell membrane repolarization | 1.06e-03 | 41 | 101 | 3 | GO:0099622 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization | 1.06e-03 | 41 | 101 | 3 | GO:0060306 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.08e-03 | 324 | 101 | 7 | GO:0006302 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1C CACNA1D CACNA1F CACNA1S CCDC22 PTPMT1 PTCH1 BDKRB1 CRY1 ADIPOR1 KCNJ2 TBC1D1 LRP1 ATP1A4 ADIPOR2 | 1.09e-03 | 1249 | 101 | 15 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.09e-03 | 92 | 101 | 4 | GO:0061178 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 1.32e-05 | 10 | 102 | 3 | GO:0031390 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.40e-05 | 12 | 102 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.45e-05 | 46 | 102 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | stereocilium tip | 1.62e-04 | 22 | 102 | 3 | GO:0032426 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.49e-04 | 73 | 102 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 6.06e-04 | 79 | 102 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.99e-04 | 85 | 102 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | endonuclease complex | 1.21e-03 | 43 | 102 | 3 | GO:1905348 | |
| HumanPheno | Complex cardiac malformations | CACNA1C CCDC22 ERCC4 CHD4 RFC2 PTCH1 DDX11 FKTN NME5 SMARCD1 KDM6A DNAH11 | 6.23e-08 | 257 | 35 | 12 | HP:0002565 |
| HumanPheno | Abnormal ventriculoarterial connection | CACNA1C CCDC22 ERCC4 CHD4 RFC2 PTCH1 DDX11 FKTN NME5 SMARCD1 KDM6A DNAH11 | 1.61e-07 | 280 | 35 | 12 | HP:0011563 |
| HumanPheno | Abnormal connection of the cardiac segments | CACNA1C CCDC22 ERCC4 CHD4 RFC2 PTCH1 DDX11 FKTN NME5 SMARCD1 KDM6A DNAH11 | 1.88e-07 | 284 | 35 | 12 | HP:0011545 |
| HumanPheno | Conotruncal defect | CACNA1C CCDC22 ERCC4 CHD4 RFC2 PTCH1 DDX11 NME5 SMARCD1 KDM6A DNAH11 | 8.08e-07 | 264 | 35 | 11 | HP:0001710 |
| HumanPheno | Tetralogy of Fallot | 2.82e-06 | 185 | 35 | 9 | HP:0001636 | |
| HumanPheno | Ectopic anus | 3.34e-05 | 93 | 35 | 6 | HP:0004397 | |
| HumanPheno | Abnormal anus morphology | 1.04e-04 | 224 | 35 | 8 | HP:0034915 | |
| HumanPheno | Congenital malformation of the great arteries | CACNA1C CCDC22 ERCC4 CHD4 RFC2 PTCH1 DDX11 FKTN NME5 SMARCD1 KDM6A DNAH11 | 1.23e-04 | 529 | 35 | 12 | HP:0011603 |
| HumanPheno | Abnormal cardiac atrium morphology | CACNA1C CACNA1D CCDC22 ERCC4 CHD3 CHD4 PIGG RFC2 FKTN NME5 SMARCD1 KDM6A DNAH11 | 1.23e-04 | 617 | 35 | 13 | HP:0005120 |
| HumanPheno | Abnormality of the anus | 1.99e-04 | 246 | 35 | 8 | HP:0004378 | |
| MousePheno | small mandibular coronoid process | 1.27e-05 | 9 | 76 | 3 | MP:0030283 | |
| Domain | VDCC_L_a1su | 6.84e-10 | 4 | 97 | 4 | IPR005446 | |
| Domain | VDCC_a1su_IQ | 2.36e-08 | 7 | 97 | 4 | IPR014873 | |
| Domain | GPHH | 2.36e-08 | 7 | 97 | 4 | PF16905 | |
| Domain | GPHH_dom | 2.36e-08 | 7 | 97 | 4 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.36e-08 | 7 | 97 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 2.36e-08 | 7 | 97 | 4 | PF08763 | |
| Domain | CAC1F_C | 1.36e-07 | 3 | 97 | 3 | IPR031688 | |
| Domain | CAC1F_C | 1.36e-07 | 3 | 97 | 3 | PF16885 | |
| Domain | VDCCAlpha1 | 1.40e-07 | 10 | 97 | 4 | IPR002077 | |
| Domain | DHC_N1 | 7.46e-06 | 8 | 97 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.46e-06 | 8 | 97 | 3 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.74e-05 | 14 | 97 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.74e-05 | 14 | 97 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.74e-05 | 14 | 97 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.74e-05 | 14 | 97 | 3 | PF08393 | |
| Domain | MT | 4.74e-05 | 14 | 97 | 3 | PF12777 | |
| Domain | AAA_8 | 4.74e-05 | 14 | 97 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 4.74e-05 | 14 | 97 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.74e-05 | 14 | 97 | 3 | PF07728 | |
| Domain | DHC_fam | 5.91e-05 | 15 | 97 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.91e-05 | 15 | 97 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 5.91e-05 | 15 | 97 | 3 | PF03028 | |
| Domain | CHDCT2 | 7.98e-05 | 3 | 97 | 2 | PF08074 | |
| Domain | CHDNT | 7.98e-05 | 3 | 97 | 2 | PF08073 | |
| Domain | DUF1086 | 7.98e-05 | 3 | 97 | 2 | IPR009462 | |
| Domain | DUF1087 | 7.98e-05 | 3 | 97 | 2 | IPR009463 | |
| Domain | CHD_N | 7.98e-05 | 3 | 97 | 2 | IPR012958 | |
| Domain | CHD_C2 | 7.98e-05 | 3 | 97 | 2 | IPR012957 | |
| Domain | DUF1087 | 7.98e-05 | 3 | 97 | 2 | PF06465 | |
| Domain | DUF1086 | 7.98e-05 | 3 | 97 | 2 | PF06461 | |
| Domain | DUF1087 | 7.98e-05 | 3 | 97 | 2 | SM01147 | |
| Domain | DUF1086 | 7.98e-05 | 3 | 97 | 2 | SM01146 | |
| Domain | Channel_four-helix_dom | 2.19e-04 | 57 | 97 | 4 | IPR027359 | |
| Domain | - | 2.19e-04 | 57 | 97 | 4 | 1.20.120.350 | |
| Domain | ERCC4 | 2.64e-04 | 5 | 97 | 2 | SM00891 | |
| Domain | ERCC4_domain | 2.64e-04 | 5 | 97 | 2 | IPR006166 | |
| Domain | ERCC4 | 2.64e-04 | 5 | 97 | 2 | PF02732 | |
| Domain | Ion_trans_dom | 3.20e-04 | 114 | 97 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.20e-04 | 114 | 97 | 5 | PF00520 | |
| Domain | P-loop_NTPase | DYNC2H1 CHD3 CHD4 RFC2 ZRANB3 DDX11 SLFN13 ASPM HS3ST3B1 HS3ST3A1 DYNC1H1 NLRP8 DNAH11 | 4.35e-04 | 848 | 97 | 13 | IPR027417 |
| Domain | - | DYNC2H1 CHD3 CHD4 RFC2 ZRANB3 DDX11 SLFN13 HS3ST3B1 HS3ST3A1 DYNC1H1 NLRP8 DNAH11 | 4.79e-04 | 746 | 97 | 12 | 3.40.50.300 |
| Domain | SNF2_N | 6.04e-04 | 32 | 97 | 3 | IPR000330 | |
| Domain | SNF2_N | 6.04e-04 | 32 | 97 | 3 | PF00176 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.88e-04 | 35 | 97 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.00e-03 | 38 | 97 | 3 | PS00690 | |
| Domain | AdipoR/HlyIII-related | 1.42e-03 | 11 | 97 | 2 | IPR004254 | |
| Domain | HlyIII | 1.42e-03 | 11 | 97 | 2 | PF03006 | |
| Domain | Cyt_P450_E_grp-I | 1.65e-03 | 45 | 97 | 3 | IPR002401 | |
| Domain | Znf_UBP | 2.33e-03 | 14 | 97 | 2 | IPR001607 | |
| Domain | zf-UBP | 2.33e-03 | 14 | 97 | 2 | PF02148 | |
| Domain | ZF_UBP | 2.33e-03 | 14 | 97 | 2 | PS50271 | |
| Domain | Cyt_P450_CS | 2.64e-03 | 53 | 97 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 3.24e-03 | 57 | 97 | 3 | PS00086 | |
| Domain | - | 3.41e-03 | 58 | 97 | 3 | 1.10.630.10 | |
| Domain | p450 | 3.41e-03 | 58 | 97 | 3 | PF00067 | |
| Domain | Cyt_P450 | 3.75e-03 | 60 | 97 | 3 | IPR001128 | |
| Domain | DSRM | 4.31e-03 | 19 | 97 | 2 | SM00358 | |
| Domain | dsrm | 4.77e-03 | 20 | 97 | 2 | PF00035 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.36e-08 | 6 | 79 | 4 | M47762 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 8.76e-07 | 14 | 79 | 4 | M47692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.46e-06 | 23 | 79 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.06e-05 | 25 | 79 | 4 | M47948 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 3.30e-05 | 33 | 79 | 4 | MM15963 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 3.33e-05 | 66 | 79 | 5 | M101 | |
| Pathway | REACTOME_EICOSANOIDS | 3.59e-05 | 12 | 79 | 3 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.59e-05 | 12 | 79 | 3 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 3.59e-05 | 12 | 79 | 3 | MM14845 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.79e-05 | 74 | 79 | 5 | MM15962 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 5.90e-05 | 14 | 79 | 3 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 7.34e-05 | 15 | 79 | 3 | M27126 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 7.93e-05 | 79 | 79 | 5 | M17673 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.30e-04 | 18 | 79 | 3 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.30e-04 | 18 | 79 | 3 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.09e-04 | 21 | 79 | 3 | M27137 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.29e-04 | 59 | 79 | 4 | M27140 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.56e-04 | 25 | 79 | 3 | MM14858 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.74e-04 | 61 | 79 | 4 | MM14861 | |
| Pathway | REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY | 4.58e-04 | 6 | 79 | 2 | MM14630 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 7.04e-04 | 72 | 79 | 4 | MM14631 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 7.81e-04 | 74 | 79 | 4 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 7.81e-04 | 74 | 79 | 4 | M39462 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 8.19e-04 | 33 | 79 | 3 | MM15918 | |
| Pathway | REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY | 8.49e-04 | 8 | 79 | 2 | M26990 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.20e-03 | 83 | 79 | 4 | M8728 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 1.36e-03 | 10 | 79 | 2 | M39539 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 1.36e-03 | 10 | 79 | 2 | MM15824 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.62e-03 | 90 | 79 | 4 | M835 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.65e-03 | 11 | 79 | 2 | M22027 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.65e-03 | 11 | 79 | 2 | MM14863 | |
| Pathway | BIOCARTA_PTC1_PATHWAY | 1.65e-03 | 11 | 79 | 2 | M13022 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.65e-03 | 11 | 79 | 2 | M47958 | |
| Pathway | BIOCARTA_PTC1_PATHWAY | 1.65e-03 | 11 | 79 | 2 | MM1499 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.66e-03 | 42 | 79 | 3 | M7169 | |
| Pathway | KEGG_NUCLEOTIDE_EXCISION_REPAIR | 1.90e-03 | 44 | 79 | 3 | M18937 | |
| Pathway | WP_NUCLEOTIDE_EXCISION_REPAIR | 1.90e-03 | 44 | 79 | 3 | M39847 | |
| Pubmed | 5.30e-13 | 12 | 103 | 6 | 14557543 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 20937870 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.62e-10 | 5 | 103 | 4 | 12629516 | |
| Pubmed | 2.52e-09 | 7 | 103 | 4 | 12900400 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.35e-08 | 94 | 103 | 7 | 21542922 | |
| Pubmed | 1.50e-08 | 10 | 103 | 4 | 12970426 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 17767505 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 2173707 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 17289261 | ||
| Pubmed | 9.66e-08 | 15 | 103 | 4 | 20188150 | ||
| Pubmed | 9.66e-08 | 15 | 103 | 4 | 24453333 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 1.01e-07 | 4 | 103 | 3 | 18065749 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 9068972 | ||
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 15063128 | ||
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 28330839 | ||
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 16382099 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.80e-06 | 139 | 103 | 6 | 16985003 | |
| Pubmed | 4.09e-06 | 11 | 103 | 3 | 18809727 | ||
| Pubmed | 6.11e-06 | 40 | 103 | 4 | 32317081 | ||
| Pubmed | Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. | 8.69e-06 | 2 | 103 | 2 | 19062045 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24969908 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25277766 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 8.69e-06 | 2 | 103 | 2 | 7560064 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22534793 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19909601 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29237572 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17416799 | ||
| Pubmed | Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma. | 8.69e-06 | 2 | 103 | 2 | 24619866 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 1281468 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19549705 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21054386 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18923878 | ||
| Pubmed | Dual action of adiponectin on insulin secretion in insulin-resistant mice. | 8.69e-06 | 2 | 103 | 2 | 15358228 | |
| Pubmed | Regulation of adiponectin receptor gene expression in diabetic mice. | 8.69e-06 | 2 | 103 | 2 | 15613685 | |
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 8.69e-06 | 2 | 103 | 2 | 25966695 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30890562 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7575689 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22475533 | ||
| Pubmed | The regulation of adiponectin receptors in human prostate cancer cell lines. | 8.69e-06 | 2 | 103 | 2 | 16899222 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24086669 | ||
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 8.69e-06 | 2 | 103 | 2 | 16440056 | |
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 8.69e-06 | 2 | 103 | 2 | 26049024 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25892445 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23255609 | ||
| Pubmed | Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. | 8.69e-06 | 2 | 103 | 2 | 17716299 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20470935 | ||
| Pubmed | Adipo-R1 and adipo-R2 expression in colorectal adenomas and carcinomas. | 8.69e-06 | 2 | 103 | 2 | 25640382 | |
| Pubmed | The expression and relationship of AdipoR1/R2 in gastric intestinal metaplasia. | 8.69e-06 | 2 | 103 | 2 | 33851685 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18310295 | ||
| Pubmed | The effect of renal transplantation on adiponectin and its isoforms and receptors. | 8.69e-06 | 2 | 103 | 2 | 17697862 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 8.69e-06 | 2 | 103 | 2 | 16706838 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23761887 | ||
| Pubmed | Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. | 8.69e-06 | 2 | 103 | 2 | 18466348 | |
| Pubmed | Association of ADIPOR2 with liver function tests in type 2 diabetic subjects. | 8.69e-06 | 2 | 103 | 2 | 18719649 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14981074 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18971219 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 8.69e-06 | 2 | 103 | 2 | 25292336 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25855295 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15105989 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17526649 | ||
| Pubmed | Adiponectin receptors are downregulated in human gastric cancer. | 8.69e-06 | 2 | 103 | 2 | 20336470 | |
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 8.69e-06 | 2 | 103 | 2 | 28978442 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 12606379 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8833153 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 8.69e-06 | 2 | 103 | 2 | 24941892 | |
| Pubmed | Structural insights into adiponectin receptors suggest ceramidase activity. | 8.69e-06 | 2 | 103 | 2 | 28329765 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17118803 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26459399 | ||
| Pubmed | A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis. | 8.69e-06 | 2 | 103 | 2 | 37948516 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22000082 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19500219 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16609881 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 8.69e-06 | 2 | 103 | 2 | 16921373 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24470632 | ||
| Pubmed | The distribution of adiponectin receptors on human peripheral blood mononuclear cells. | 8.69e-06 | 2 | 103 | 2 | 19120283 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19671624 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24760982 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32750056 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15983228 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20028965 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20014384 | ||
| Pubmed | Adiponectin and adiponectin receptor in relation to colorectal cancer progression. | 8.69e-06 | 2 | 103 | 2 | 21351255 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24138531 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15331527 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 28145500 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30001160 | ||
| Pubmed | AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice. | 8.69e-06 | 2 | 103 | 2 | 33420419 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21352396 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18988888 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 8.69e-06 | 2 | 103 | 2 | 8026587 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9325061 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 8.69e-06 | 2 | 103 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 8.69e-06 | 2 | 103 | 2 | 16267232 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25392268 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15918014 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18842004 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9060628 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24996399 | ||
| GeneFamily | Calcium voltage-gated channel subunits | 2.89e-06 | 26 | 70 | 4 | 253 | |
| GeneFamily | Adiponectin receptors|Progestin and adipoQ receptor family | 1.48e-05 | 2 | 70 | 2 | 293 | |
| GeneFamily | Cytochrome P450 family 4 | 3.62e-04 | 36 | 70 | 3 | 1003 | |
| GeneFamily | Progestin and adipoQ receptor family | 7.95e-04 | 11 | 70 | 2 | 930 | |
| GeneFamily | PHD finger proteins|NuRD complex | 9.51e-04 | 12 | 70 | 2 | 1305 | |
| GeneFamily | Dyneins, cytoplasmic | 1.12e-03 | 13 | 70 | 2 | 538 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.96e-03 | 21 | 70 | 2 | 89 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-07 | 191 | 97 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 176 | 97 | 6 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 176 | 97 | 6 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-06 | 189 | 97 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.20e-05 | 154 | 97 | 5 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.20e-05 | 154 | 97 | 5 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.20e-05 | 154 | 97 | 5 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.20e-05 | 154 | 97 | 5 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 159 | 97 | 5 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 173 | 97 | 5 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-05 | 179 | 97 | 5 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.64e-05 | 180 | 97 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 183 | 97 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 183 | 97 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 183 | 97 | 5 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 186 | 97 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.56e-05 | 187 | 97 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.85e-05 | 189 | 97 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 189 | 97 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-05 | 191 | 97 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-05 | 192 | 97 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 195 | 97 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 195 | 97 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-05 | 196 | 97 | 5 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-05 | 196 | 97 | 5 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 197 | 97 | 5 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 197 | 97 | 5 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-MAIT|ICU-NoSEP / Disease, condition lineage and cell class | 7.64e-05 | 200 | 97 | 5 | 4f03b5f4110ed1637ffe17cb6ff309265a3af9a8 | |
| Drug | Cinnarizine | 4.00e-08 | 9 | 98 | 4 | DB00568 | |
| Drug | Nimodipine | 4.00e-08 | 9 | 98 | 4 | DB00393 | |
| Drug | Mibefradil | 1.04e-07 | 11 | 98 | 4 | DB01388 | |
| Drug | Verapamil | 5.64e-07 | 16 | 98 | 4 | DB00661 | |
| Drug | Nisoldipine | 7.68e-07 | 5 | 98 | 3 | DB00401 | |
| Drug | Nilvadipine | 7.68e-07 | 5 | 98 | 3 | DB06712 | |
| Drug | CPU-23 | 1.53e-06 | 6 | 98 | 3 | CID003036051 | |
| Drug | Amlodipine | 2.67e-06 | 7 | 98 | 3 | DB00381 | |
| Drug | Isradipine | 2.67e-06 | 7 | 98 | 3 | DB00270 | |
| Drug | Nifedipine | 4.26e-06 | 8 | 98 | 3 | DB01115 | |
| Drug | Nitrendipine | 4.26e-06 | 8 | 98 | 3 | DB01054 | |
| Drug | lercanidipine | 7.69e-06 | 63 | 98 | 5 | CID000065866 | |
| Drug | felodipine | 8.60e-06 | 169 | 98 | 7 | CID000003333 | |
| Drug | CNS 1145 | 1.20e-05 | 33 | 98 | 4 | CID000190902 | |
| Drug | IHC-64 | 1.20e-05 | 33 | 98 | 4 | CID000162753 | |
| Drug | Felodipine | 1.24e-05 | 11 | 98 | 3 | DB01023 | |
| Drug | ethosuximide | 1.70e-05 | 74 | 98 | 5 | CID000003291 | |
| Drug | RA 56 | 1.83e-05 | 2 | 98 | 2 | CID005746926 | |
| Drug | AC1O4QX2 | 1.83e-05 | 2 | 98 | 2 | CID006399062 | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.40e-05 | 198 | 98 | 7 | 3548_UP | |
| Drug | AC1L1JG6 | 2.72e-05 | 14 | 98 | 3 | CID000005026 | |
| Drug | FPL 64176 | 3.39e-05 | 15 | 98 | 3 | CID000003423 | |
| Drug | AC1L1WTA | 5.49e-05 | 3 | 98 | 2 | CID000011190 | |
| Drug | KW-3049 | 6.38e-05 | 50 | 98 | 4 | CID000002324 | |
| Drug | azelnidipine | 6.91e-05 | 51 | 98 | 4 | CID000065948 | |
| Drug | paraoxon | 7.76e-05 | 164 | 98 | 6 | CID000009395 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.01e-10 | 4 | 95 | 4 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.49e-06 | 36 | 95 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.88e-04 | 163 | 95 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Muscular Dystrophy | 2.84e-04 | 8 | 95 | 2 | C0026850 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.64e-04 | 9 | 95 | 2 | EFO_0800562 | |
| Disease | Shortened QT interval | 5.54e-04 | 11 | 95 | 2 | C0151879 | |
| Disease | Basal cell carcinoma | 5.54e-04 | 11 | 95 | 2 | C0007117 | |
| Disease | hypertension (biomarker_via_orthology) | 8.52e-04 | 227 | 95 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.05e-03 | 15 | 95 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.36e-03 | 148 | 95 | 4 | C0279702 | |
| Disease | wellbeing measurement | 1.78e-03 | 692 | 95 | 8 | EFO_0007869 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 1.88e-03 | 20 | 95 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | Deep Vein Thrombosis | 2.07e-03 | 21 | 95 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 2.07e-03 | 21 | 95 | 2 | C0042487 | |
| Disease | Schizophrenia | 2.19e-03 | 883 | 95 | 9 | C0036341 | |
| Disease | Cardiac Arrhythmia | 2.93e-03 | 25 | 95 | 2 | C0003811 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.17e-03 | 26 | 95 | 2 | DOID:234 (is_implicated_in) | |
| Disease | migraine disorder, pulse pressure measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0005763, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHHRITYLDKGSWLL | 666 | Q9UKU6 | |
| LHYTDWLHPEDPARL | 411 | P22303 | |
| GVKYAAELHLVHWNP | 111 | P07451 | |
| LIRKGIPHHFRAIVW | 111 | Q96CN4 | |
| LLLPHEAWHFARIVE | 191 | P46663 | |
| HLWLHESARVYGDKL | 2736 | Q96DT5 | |
| WVEKHVGSPAHLAYR | 391 | Q8WYK0 | |
| LPDRLKWYLLSEHSG | 401 | Q9NWX5 | |
| HLAGQWEKHRVPLLA | 416 | O60826 | |
| WEKHRVPLLAEYRHL | 421 | O60826 | |
| WRAILPAKIAHEHFL | 3011 | Q8IZT6 | |
| KDEIRHWILPQDYDH | 266 | Q15293 | |
| EKHGLQPALLVHWAE | 566 | P49792 | |
| RLWIGNLDPKITEYH | 26 | Q96H35 | |
| LPDWLKDNDFLLHGH | 111 | Q86V24 | |
| HPAGHLVLKWLIEQD | 551 | Q15397 | |
| LWGHRYEPVLFEEKH | 321 | P63252 | |
| DAGDHYPLHLLVWKN | 6 | Q8IZ07 | |
| YLTRDWSILGPHHLD | 1446 | O60840 | |
| WSILGPHHLDEFKRI | 1451 | O60840 | |
| AARFGHPVLVEWLLH | 111 | Q6ZVH7 | |
| PDWLKDNDYLLHGHR | 101 | Q96A54 | |
| IQIGIYAKHLEHWLR | 271 | Q9Y662 | |
| HLIYGEPRKLLTQDW | 261 | P43363 | |
| DEGAKHIWNALPHLR | 881 | Q86W28 | |
| GLVVHPLRGKLYWTD | 1706 | Q07954 | |
| EIIWHGRTKEEPAHY | 1316 | O15550 | |
| ERPYLEHKIGWLDSL | 426 | Q9H252 | |
| LKWDFDNRPHILHGE | 596 | P05160 | |
| RKDPKYREWHHFLVV | 76 | P30086 | |
| RHKAISYWLELLGPN | 86 | P56597 | |
| LRLNYIHWVEDLIGH | 81 | Q86W50 | |
| HLKHLEIDYWPLLDM | 226 | Q7L985 | |
| IQIGIYAKHLEHWLR | 286 | Q9Y663 | |
| PGALYAHDALRLWEI | 456 | P18054 | |
| EYLRQVHAHWEKGGL | 711 | Q96FC9 | |
| IDRHLGEPHKFKREW | 91 | Q9Y5U4 | |
| YLDWIHGHIRDKEAP | 441 | P04070 | |
| DWYHRIDPTVLLGAL | 36 | Q8WUK0 | |
| LDSIAHGHRLIPYDW | 336 | Q9YNA8 | |
| HGHRLIPYDWEILAK | 341 | Q9YNA8 | |
| LDSIAHGHRLIPYDW | 336 | P62683 | |
| HGHRLIPYDWEILAK | 341 | P62683 | |
| LDSIAHGHRLIPYDW | 336 | Q7LDI9 | |
| HGHRLIPYDWEILAK | 341 | Q7LDI9 | |
| LDSIAHGHRLIPYDW | 336 | P63130 | |
| HGHRLIPYDWEILAK | 341 | P63130 | |
| LDSIAHGHRLIPYDW | 336 | P62685 | |
| HGHRLIPYDWEILAK | 341 | P62685 | |
| LDSIAHGHRLIPYDW | 336 | P63126 | |
| HGHRLIPYDWEILAK | 341 | P63126 | |
| LDSIAHGHRLIPYDW | 336 | P62684 | |
| HGHRLIPYDWEILAK | 341 | P62684 | |
| ILKYVRGEHLSPDHW | 1196 | Q8NCM8 | |
| ILGPHHLDEFKRIWA | 1536 | Q13936 | |
| YLTRDWSILGPHHLD | 1386 | Q13698 | |
| WSILGPHHLDEFKAI | 1391 | Q13698 | |
| EYLHQHWILHRDLKP | 126 | P50613 | |
| ENVDPDYWEKLLRHH | 1311 | Q12873 | |
| GLSWVLYHLAKHPEY | 336 | Q9HBI6 | |
| VHWFRKGLRLHDNPA | 6 | Q16526 | |
| WIHRHPKAEDLRVGL | 6 | Q9NQT6 | |
| YLRQVHAHWEKGGLL | 731 | Q92771 | |
| GLSWVLYHLAKHPEY | 336 | P78329 | |
| GNYLWHGHLRLKEHI | 181 | O75072 | |
| AKPDALHGLRVHSWV | 291 | Q8IY82 | |
| RHEALLYTWLAEHKP | 2576 | Q14204 | |
| VEVLGHLPKRFSWFH | 21 | Q587J8 | |
| GLSWVLYHLAKHPEY | 336 | Q08477 | |
| ARPHLAVIGLDAYLW | 176 | A4GXA9 | |
| GDADYLAAWHRLVLP | 711 | Q9UBN7 | |
| AWLRVVLEKPFGHDH | 166 | O95479 | |
| GHVHYLIKWRDLPYD | 636 | Q14839 | |
| WHHHDKDGRPLYVLR | 331 | Q92503 | |
| LLAGVAYAVPHWRHL | 236 | Q4U2R8 | |
| IPHGYLAILSEAKWV | 756 | Q68D06 | |
| ILGPHHLDEFKRIWS | 1476 | Q01668 | |
| LDWPAVALHLGVSYR | 801 | Q9HB75 | |
| PDKDWFHLVGLLHDL | 111 | Q9UGB7 | |
| ALGWKAVERVLYPHL | 316 | Q9Y6J9 | |
| ELLPLLHAAWDHYRI | 436 | A8K8P3 | |
| KKAHPDRLHDELWYN | 511 | Q9NRR4 | |
| LAHRPWLITKEHIEG | 171 | Q9Y6P5 | |
| GLHWHDYRDLLPGIL | 2161 | A2VEC9 | |
| KDLYGPDNHLVEWHR | 246 | Q96GM5 | |
| WHIDYRGHGALPDLE | 411 | Q6IEE7 | |
| IRPHRPEWVHDKADY | 941 | Q13635 | |
| HKFPHVRQLESLGWD | 91 | Q9BR10 | |
| FRVLLWGPAAVEHHK | 1561 | O60287 | |
| LDSIAHGHRLIPYDW | 336 | P63128 | |
| HGHRLIPYDWEILAK | 341 | P63128 | |
| EDYHPLIALKWLLGR | 431 | Q8TDI8 | |
| PVDLLGIRLHWEDKY | 886 | Q13733 | |
| LARHWRVHTGEKPYK | 501 | Q9H7R5 | |
| LHYSEWHRKKQAGIP | 16 | Q9Y5R8 | |
| HIPYKLLHLIWIHAE | 426 | Q70EK9 | |
| ELHISYRWDPNLKGL | 71 | P60508 | |
| LKAHLRWHTGERPFV | 311 | Q8TDD2 | |
| DVLPHELYWRLKRHL | 111 | A6NFA1 | |
| VPRHHRGEIWKFLAE | 801 | Q86TI0 | |
| KPLHYISWLVGHEGK | 456 | O43847 | |
| ILAHLWHLGYSPEDI | 281 | P35250 | |
| LGRYPIHWHLLGDLQ | 2471 | Q86WI1 | |
| LILRPLTKEAHGHWE | 471 | Q9P2J2 | |
| ERYWGRLLHKLEHEV | 46 | Q14166 | |
| EGEKHWRLYHPTVPL | 191 | Q8IUF8 | |
| LQELAIHHGWRLPEY | 131 | O75569 | |
| LAQHWRIHTGEKPYK | 386 | Q8WV37 | |
| LNDHWRLHTGEKPYE | 176 | Q13106 | |
| PFDKTIRHYLDPLWH | 261 | Q92889 | |
| IRHYLDPLWHQLGAK | 266 | Q92889 | |
| GDWDILILHYLGLDH | 206 | Q5H8A4 | |
| KWIKEPHFLHAIEYG | 216 | Q8NFY4 | |
| LIYHLEHGQEPWTRK | 61 | Q5CZA5 | |
| GLVRHWRIHTGEKPY | 336 | Q15776 | |
| QAKLRPEDGLYLIHW | 461 | P29597 | |
| HVVFAELYWDPGHIK | 411 | Q5FWF4 |